Exscientia Ltd ADR Financials
| EXAIDelisted Stock | USD 4.84 0.00 0.00% |
Exscientia |
Understanding current and past Exscientia Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Exscientia's financial statements are interrelated, with each one affecting the others. For example, an increase in Exscientia's assets may result in an increase in income on the income statement.
Exscientia Stock Summary
Exscientia competes with Zura Bio, Elevation Oncology, Recursion Pharmaceuticals, Atea Pharmaceuticals, and Unity Biotechnology. Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom. Exscientia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 285 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US30223G1022 |
| CUSIP | 30223G102 |
| Location | United Kingdom |
| Business Address | The SchrOedinger Building, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.exscientia.ai |
| Phone | 44 18 6581 8941 |
| Currency | USD - US Dollar |
Exscientia Key Financial Ratios
| Return On Equity | -0.46 | ||||
| Return On Asset | -0.21 | ||||
| Target Price | 4.35 | ||||
| Number Of Employees | 483 | ||||
| Beta | 0.84 |
Exscientia Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Exscientia's current stock value. Our valuation model uses many indicators to compare Exscientia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Exscientia competition to find correlations between indicators driving Exscientia's intrinsic value. More Info.Exscientia Ltd ADR is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Exscientia's earnings, one of the primary drivers of an investment's value.Exscientia ADR Systematic Risk
Exscientia's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Exscientia volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Exscientia ADR correlated with the market. If Beta is less than 0 Exscientia generally moves in the opposite direction as compared to the market. If Exscientia Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Exscientia ADR is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Exscientia is generally in the same direction as the market. If Beta > 1 Exscientia moves generally in the same direction as, but more than the movement of the benchmark.
About Exscientia Financials
What exactly are Exscientia Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Exscientia's income statement, its balance sheet, and the statement of cash flows. Potential Exscientia investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Exscientia investors may use each financial statement separately, they are all related. The changes in Exscientia's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Exscientia's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Exscientia November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Exscientia help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Exscientia Ltd ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of Exscientia Ltd ADR based on widely used predictive technical indicators. In general, we focus on analyzing Exscientia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Exscientia's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 21.23 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 5.52 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exscientia Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Exscientia Stock
If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |